Evaluation of endothelial cells differentiated from amniotic fluid-derived stem cells

Area of Science:

• Regenerative Medicine
• Stem Cell Biology
• Vascular Biology

Background:

• Amniotic fluid stem cells (AFSC) are a promising source for autologous cell therapies.
• Neonatal applications require readily available and functional cell sources.
• Differentiation potential of AFSC into specific cell types needs further investigation.

Purpose of the Study:

• To chemically induce differentiation of AFSC into endothelial cells.
• To functionally characterize the resulting AFSC-derived endothelial cells (AFSC-EC).
• To assess the potential of AFSC-EC in regenerative medicine.

Main Methods:

• AFSC isolated from amniotic fluid of pregnancies with twin-twin transfusion syndrome.
• AFSC cultured in endothelial growth media with varying vascular endothelial growth factor (VEGF) concentrations.
• Expression of endothelial markers (von Willebrand factor, CD31, VE-cadherin) and functional assays (network formation, LDL metabolism) performed.
• Nitrate levels measured as an indicator of nitric oxide synthesis.

Main Results:

• AFSC differentiated into AFSC-EC expressing key endothelial markers.
• CD31 expression correlated positively with VEGF concentration up to 50 ng/mL.
• AFSC-EC exhibited functional characteristics similar to human umbilical vein endothelial cells (HUVEC).
• AFSC-EC demonstrated nitric oxide synthesis, though lower than HUVEC.

Conclusions:

• AFSC can be differentiated into functional endothelial-like cells using chemical induction.
• AFSC-EC possess characteristics and functions suitable for potential regenerative medicine applications.
• This study highlights the potential of AFSC for vascularization strategies.